- Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
-
Yamagami W, Mikami M, Nagase S, Tabata T, Kobayashi Y, Kaneuchi M, Kobayashi H, Yamada H, Hasegawa K, Fujiwara H, Katabuchi H, Aoki D
- KMID: 2465192
- J Gynecol Oncol.
- 2020 Jan;31(1):e18.
- doi: 10.3802/jgo.2020.31.e18
The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for... -
- CITED
-
- Close
- SHARE
-
- Close
- ABO Blood Type and Risk of Peyronie’s Disease in Japanese Males
-
Mitsui Y, Kobayashi H, Yamabe F, Nakajima K, Nagao K
- KMID: 2530718
- World J Mens Health.
- 2022 Jul;40(3):509-516.
- doi: 10.5534/wjmh.210126
Purpose: Although multiple mechanisms associated with Peyronie’s disease (PD) have been proposed, details regarding etiologic factors, especially genetic, remain unclear. We examined the relationship of the ABO blood type system,... -
- CITED
-
- Close
- SHARE
-
- Close
- How should we treat acute kidney injury caused by renal congestion?
-
Abe M, Hemmi S, Kobayashi H
- KMID: 2547114
- Kidney Res Clin Pract.
- 2023 Jul;42(4):415-430.
- doi: 10.23876/j.krcp.22.224
Decreased kidney function is associated with increased risk of cardiovascular events and mortality, and heart failure (HF) is a wellknown risk factor for renal dysfunction. Acute kidney injury (AKI) in... -
- CITED
-
- Close
- SHARE
-
- Close
- One-step nucleic acid amplification (OSNA) assay for detecting lymph node metastasis in cervical and endometrial cancer: a preliminary study
-
Togami S, Ushiwaka T, Kitazono I, Yanazume S, Kamio M, Tanimoto A, Kobayashi H
- KMID: 2536835
- J Gynecol Oncol.
- 2022 Mar;33(2):e11.
- doi: 10.3802/jgo.2022.33.e11
Objective To evaluate the accuracy of the one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node (LN) metastasis in uterine cancer. Methods A total of 116 LNs from 30 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Nutritional Status Indicators Affecting the Tolerability of Postoperative Chemotherapy After Total Gastrectomy in Patients With Gastric Cancer
-
Toyota K, Mori M, Hirahara S, Yoshioka S, Kubota H, Yano R, Kobayashi H, Hashimoto Y, Sakashita Y, Yokoyama Y, Murakami Y, Miyamoto K
- KMID: 2535085
- J Gastric Cancer.
- 2022 Mar;22(1):56-66.
- doi: 10.5230/jgc.2022.22.e5
Purpose: Nutritional problems after gastrectomy affect continuation of postoperative chemotherapy. There have been no studies limited to total gastrectomy, which is particularly prone to nutritional problems. In this study, we... -
- CITED
-
- Close
- SHARE
-
- Close
- The International Consultation on Incontinence Questionnaire Short Form as a Substitute for 1-Hour Pad Weight Testing in the Evaluation of Urinary Incontinence in Patients With Pelvic Organ Prolapse Undergoing Surgery
-
Kuroda K, Hamamoto K, Kawamura K, Masunaga A, Kobayashi H, Horiguchi A, Ito K
- KMID: 2559300
- Int Neurourol J.
- 2024 Sep;28(3):215-224.
- doi: 10.5213/inj.2448234.117
Purpose: Stress urinary incontinence is a postoperative complication occurring in patients with pelvic organ prolapse (POP). Although the 1-hour pad test measures the degree of urinary incontinence qualitatively and quantitatively,... -
- CITED
-
- Close
- SHARE
-
- Close
- Adrenal Venous Sampling for Subtype Diagnosis of Primary Hyperaldosteronism
-
Naruse M, Tanabe A, Yamamoto K, Rakugi H, Kometani M, Yoneda T, Kobayashi H, Abe M, Ohno Y, Inagaki N, Izawa S, Sone M
- KMID: 2521944
- Endocrinol Metab.
- 2021 Oct;36(5):965-973.
- doi: 10.3803/EnM.2021.1192
Adrenal venous sampling (AVS) is the key procedure for lateralization of primary hyperaldosteronism (PA) before surgery. Identification of the adrenal veins using computed tomography (CT) and intraoperative cortisol assay facilitates... -
- CITED
-
- Close
- SHARE
-
- Close
- Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
-
Fujiwara K, Fujiwara H, Yoshida H, Satoh T, Yonemori K, Nagao S, Matsumoto T, Kobayashi H, Bourgeois H, Harter P, Mosconi AM, Vazquez IP, Reinthaller A, Fujita T, Rowe P, Pujade-Lauraine E, Ray-Coquard I
- KMID: 2526133
- J Gynecol Oncol.
- 2021 Sep;32(5):e82.
- doi: 10.3802/jgo.2021.32.e82
Objective The addition of maintenance olaparib to bevacizumab demonstrated a significant progression-free survival (PFS) benefit in patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1/ENGOT-ov25 trial (NCT02477644). We evaluated maintenance... -
- CITED
-
- Close
- SHARE
-
- Close
